Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age.

Autor: Schwarz, Tino F.1 t.schwarz@juliusspital.de, Galaj, Andrzej2, Spaczynski, Marek3, Wysocki, Jacek4, Kaufmann, Andreas M.5, Poncelet, Sylviane6, Suryakiran, Pemmaraju V.7, Folschweiller, Nicolas8, Thomas, Florence8, Lin, Lan8, Struyf, Frank8
Zdroj: Cancer Medicine. Nov2017, Vol. 6 Issue 11, p2723-2731. 9p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje